Announcements and Circulars-宜明昂科英文

Investor Relations

Information Disclosure

Announcements and Circulars Analyst Report Financial Reports Listing Documents

Next Day Disclosure Return

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August, 2026

(1) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (2) PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

(1) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (2) PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE II CLINICAL TRIAL OF IMM2510 IN COMBINATION WITH IMM27M FOR FIRST-LINE TREATMENT OF ADVANCED HCC

VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE II CLINICAL TRIAL OF IMM2510 IN COMBINATION WITH IMM27M FOR FIRST-LINE TREATMENT OF ADVANCED HCC

INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PAH TRIAL AND COMPLETION OF ENROLMENT FOR SAD AND MAD COHORTS FOR IMC-003

VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PAH TRIAL AND COMPLETION OF ENROLMENT FOR SAD AND MAD COHORTS FOR IMC-003

VOLUNTARY ANNOUNCEMENT - APPROVAL OF IND APPLICATION OF IMM0306 FOR PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY THE FDA

VOLUNTARY ANNOUNCEMENT - APPROVAL OF IND APPLICATION OF IMM0306 FOR PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY THE FDA

DATE OF BOARD MEETING

VOLUNTARY ANNOUNCEMENT - ENTERING INTO THE CAPITAL INCREASE OF A SUBSIDIARY

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July, 2026

SUPPLEMENTAL ANNOUNCEMENT - DEEMED DISPOSAL IN RELATION TO CAPITAL INCREASE OF A SUBSIDIARY

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

总计 233 12 3 4 5 6 7 8...11 12